Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical TechnologiesROCO:4138 +0.39%78 FCF Yield % is 12.93 as of Jul. 15, 2026, which is 46% above its 10-year median of 8.85. GuruFocus rates ROCO:4138 with a GF Score™ of 78/100 and a GF Value™ of NT$74.17 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Dynamic Medical Technologies ranks better than 96.02% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Dynamic Medical Technologies's FCF Yield % or its related term are showing as below:
ROCO:4138'
s FCF Yield % Range Over the Past 10 Years
Min: 1.4 Med: 8.85 Max: 19.27
Current: 12.93
During the past 13 years, the highest FCF Yield % of Dynamic Medical Technologies was 19.27%. The lowest was 1.40%. And the median was 8.85%.
ROCO:4138's FCF Yield % is ranked better than 96.02% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.43
vs ROCO:4138: 12.93
Dynamic Medical Technologies FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Dynamic Medical Technologies FCF Yield % Related Terms
Dynamic Medical Technologies FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4138 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Dynamic Medical Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies (ROCO:4138) has a FCF Yield % of 12.93 as of Jul. 15, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dynamic Medical Technologies and its competitors. This is 46% above median its historical median of 8.85. Over the past decade, Dynamic Medical Technologies' FCF Yield % has ranged from 1.40 to 19.27. According to the industry distribution chart, Dynamic Medical Technologies ranks #34 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is Dynamic Medical Technologies' FCF Yield % too high?
Dynamic Medical Technologies' current FCF Yield % of 12.93 is 46% above median its 10-year median of 8.85. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 19.27. Based on the distribution chart, Dynamic Medical Technologies ranks #34 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Dynamic Medical Technologies has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Dynamic Medical Technologies ranks #34 out of 855 companies for FCF Yield %. This places Dynamic Medical Technologies in the top 4% of its industry — outperforming the majority of peers. Historically, Dynamic Medical Technologies' own FCF Yield % has ranged from 1.40 to 19.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dynamic Medical Technologies and its competitors. Dynamic Medical Technologies's current FCF Yield % is 12.93, which is 46% above median its own 10-year median of 8.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.17, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current FCF Yield % is 12.93, which is 46% above median its 10-year median of 8.85. Dynamic Medical Technologies' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current FCF Yield % is 12.93 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.17.
GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4138:
FCF Yield %: 12.93 (46% above median its 10-year median of 8.85)
GF Value™: NT$74.17 vs. price of NT$50.90 (31.4% below fair value)
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
78GF Score
Get the complete analysis for ROCO:4138
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
